Last reviewed · How we verify
Uterine fibroids
Approved treatments
- Yselty · Obseva Ireland Ltd
- Aygestin · Duramed Res
- Orgovyx · MYOVANT SCIENCES
Relugolix is a nonpeptide GnRH receptor antagonist that competitively binds to pituitary GnRH receptors.
Pipeline
- NORETHINDRONE — Phase 3
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Uterine fibroids patent landscape — cliff calendar, originator estates, attackable patents
- Uterine fibroids treatment landscape brief
- Uterine fibroids treatment updates RSS
Frequently asked questions about Uterine fibroids
What drugs treat Uterine fibroids?
Tracked treatments include Yselty, Aygestin, Orgovyx.
What is the treatment for Uterine fibroids?
Standard treatment for Uterine fibroids includes Yselty, Aygestin, Orgovyx. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Uterine fibroids?
1 pipeline drugs tracked. Top candidates: NORETHINDRONE.
Related
- Treatment landscape: Uterine fibroids patent cliff · Uterine fibroids CI report
- Treatment: Yselty · Obseva Ireland Ltd
- Treatment: Aygestin · Duramed Res
- Treatment: Orgovyx · MYOVANT SCIENCES
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing